Related Experiment Video

Updated: Aug 22, 2026

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
10:01

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation

Published on: July 10, 2012

Fungal pneumonias in transplant recipients

Remzi Bag1

  • 1Baylor College of Medicine, Houston, Texas, USA. rbag@bcm.tmc.edu

Current Opinion in Pulmonary Medicine
|April 12, 2003
PubMed

Insights

Opportunistic fungal pneumonias, especially invasive pulmonary aspergillosis, are rising in immunocompromised patients. Diagnosis is difficult, but new antifungal drugs offer improved treatment options.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Immunocompromised Host Research

Background:

  • Fungal infections are increasingly prevalent, particularly in immunocompromised individuals.
  • Invasive pulmonary aspergillosis (IPA) is a significant concern in hematopoietic stem cell and lung transplant recipients.
  • The clinical presentation of IPA is diverse, making early diagnosis challenging.

Purpose of the Study:

  • To review the current landscape of opportunistic fungal pneumonias.
  • To discuss diagnostic challenges and emerging detection methods for IPA.
  • To evaluate current and future therapeutic strategies for IPA.

Main Methods:

  • Literature review of opportunistic fungal pneumonias, focusing on Aspergillus species.
  • Analysis of diagnostic modalities, including culture, antigen, and DNA detection.
  • Assessment of prophylactic, preemptive, and therapeutic interventions for IPA.

Main Results:

  • Aspergillus species are the most common cause of opportunistic fungal pneumonia in susceptible populations.
  • Traditional diagnostic methods like respiratory specimen culture have limited sensitivity.
  • Circulating fungal biomarkers and novel antifungal agents show promise but require further validation.
  • The efficacy of prophylactic and preemptive treatments for IPA remains debated.

Conclusions:

  • IPA poses a significant diagnostic and therapeutic challenge in immunocompromised patients.
  • Advancements in diagnostic techniques and the development of new antifungal drugs are crucial for improving patient outcomes.
  • Further research is needed to optimize diagnostic strategies and clarify the role of prophylactic and preemptive therapies.

More Related Videos

Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation06:15

Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation

Published on: November 10, 2023

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation07:28

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...